Matthias H. Tschöp

机构：Helmholtz Munich, Deutsches Diabetes-Zentrum e.V., German Center for Diabetes Research, Heinrich Heine University Düsseldorf, Ludwig-Maximilians-Universität München · ORCID：0000-0002-4744-371X

发表论文 470 篇 · 总被引 58187 次 · h-index 114

代表论文

• Definition and diagnostic criteria of clinical obesity (2025 · The Lancet Diabetes & Endocrinology · 被引 1674)
• GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications (2023 · Cell Metabolism · 被引 149)
• Hypothalamic astrocytes control systemic glucose metabolism and energy balance (2022 · Cell Metabolism · 被引 140)
• The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets (2023 · Nature Metabolism · 被引 122)
• Transforming obesity: The advancement of multi-receptor drugs (2024 · Cell · 被引 120)
• Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice (2023 · Nature Metabolism · 被引 111)